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Abstract
Unprotected sexual intercourse between individuals who are both infected with HIV-1 can lead to exposure to their
partner’s virus, and potentially to super-infection. However, the immunological consequences of continued exposure to
HIV-1 by individuals already infected, has to our knowledge never been reported. We measured T cell responses in 49 HIV-1
infected individuals who were on antiretroviral therapy with suppressed viral loads. All the individuals were in a long-term
sexual partnership with another HIV-1 infected individual, who was either also on HAART and suppressing their viral loads,
or viremic (.9000 copies/ml). T cell responses to HIV-1 epitopes were measured directly ex-vivo by the IFN-c enzyme linked
immuno-spot assay and by cytokine flow cytometry. Sexual exposure data was generated from questionnaires given to
both individuals within each partnership. Individuals who continued to have regular sexual contact with a HIV-1 infected
viremic partner had significantly higher frequencies of HIV-1-specific T cell responses, compared to individuals with aviremic
partners. Strikingly, the magnitude of the HIV-1-specific T cell response correlated strongly with the level and route of
exposure. Responses consisted of both CD4+ and CD8+ T cell subsets. Longitudinally, decreases in exposure were mirrored
by a lower T cell response. However, no evidence for systemic super-infection was found in any of the individuals.
Continued sexual exposure to exogenous HIV-1 was associated with increased HIV-1-specific T cell responses, in the
absence of systemic super-infection, and correlated with the level and type of exposure.
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Introduction
Immune responses seen during chronic viral infections are
thought to be driven only by ‘endogenous’ virus. However,
continued exposure to ‘exogenous’ virus could boost anti-viral
immunity. HIV-1 infection provides a model to test this
hypothesis. Continued sexual intercourse between two HIV-1
infected individuals leads to exposure to exogenous HIV-1. Recent
reports have shown that there is a growing trend for serosorting,
the practice of seeking to only engage in unprotected sexual
activities with partners who are of the same HIV-1 status [1,2].
This provides a model system in which to investigate the influence
of exogenous versus endogenous viral exposure on immunity to a
chronic virus infection. Moreover, given the potential risks of
super-infection upon re-exposure to HIV-1, understanding the
immune responses involved is particularly important [3,4].
CD8+ T cells are thought to play an important role in
controlling HIV-1. Model viral infections, such as lymphocytic
choriomeningitis (LCMV) and simian immunodeficiency virus
(SIV), have shown that the CD8+ T cell response is a crucial
component in the control or elimination of viral infections [5,6,7].
Moreover, the power of CD8+ T cell responses have been
elegantly shown to be a driving force in the selection of escape
variants in SIV [8].
The immune response towards HIV-1 is complex; we set out to
determine if T cell mediated responses in an HIV-1 infected
individual can be stimulated through exposure to exogenous virus.
However, even this simple question has its complexities, as
responses to exogenous virus are indistinguishable from responses
directed toward the primary infecting virus. To address this we
selected individuals with suppressed viral loads while on
antiretroviral therapy. Previous studies have shown that viral
suppression by highly active antiretroviral therapy (HAART) to
below 50 copies/ml leads to the subsequent waning of anti-HIV-1
T cell responses, due to the reduction in viral antigen [9,10,11].
Therefore, we hypothesized that individuals with suppressed viral
loads while on HAART, who are regularly exposed to an HIV-1
viremic partner, would have greater anti-HIV-1 specific T cell
responses compared to individuals who are exposed to a non-
viremic partner.
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Results
Patient groups
We studied 49 individuals from the San Francisco Positive
Partners prospective couples cohort who were suppressing their
virus while on HAART. The subjects were divided into two groups
depending on the viral status of their partner, the viremic partner
(VP) group, and the non-viremic partner (NVP) group. These
groups did not differ in terms of the clinical parameters, such as
age, time on therapy, CD4+ T cell count and viral loads (Table 1),
or the level of sexual activity, as defined by the exposure score or
the average number of insertive or receptive exposures (Table 2).
However, there was a trend for higher levels of exposure in the
subjects from the NVP group.
Sexual exposure to a viremic partner boosts HIV-1 T cell
specific responses
Analysis of T cell IFN-c responses revealed significantly more
individuals from the VP group made responses (as defined in the
materials and methods section) to HIV-1 Protease and Integrase
peptides, compared to individuals with the NVP group (Figure 1A).
However, there was no difference in the percentage of individuals
from each group making responses to HIV-1 Gag, Reverse
Transcriptase (RT), Nef, or CEF. Further analysis of the
individuals who made responses revealed that there was no
significant difference in the magnitude of the responses made to
either of these proteins (Figure 1B). However, Protease, RT, and
Integrase (p,0.001) responses were significantly higher in the VP
group compared to the NVP group. Overall, there was a trend
towards a higher magnitude of response to HIV-1 Gag, Protease,
Integrase and Nef by individuals with viremic partners (VP group).
Moreover, cumulatively there was a significantly higher anti-HIV-
1 T cell response made by the VP group (p= 0.0274).
Frequency of continued sexual exposure determines the
magnitude of the HIV-1-specific T cell response
We further explored the behavioral influence of exposure on the
T cell response by utilizing data on the frequency of unprotected
sexual intercourse in the partnerships. The exposure scores were
plotted against the magnitudes of IFN-c responses for individuals
within each group (Figure 2). Individuals from the VP group
showed strong correlations between their level of exposure and
their T cell responses to peptide pools corresponding to HIV-1
Protease, RT, Integrase and Nef (Figure 2A). Gag and CEF
peptide pools showed no significant correlation, although Gag
responses did follow the same trend as the other HIV-1 proteins.
In contrast, no correlations were found between the exposure
scores and IFN-c responses made by individuals whose partners
were suppressing their virus (NVP group) (Figure 2B). Thus, not
only is the level of exposure important in determining the
magnitude of the T cell response, but critically it is exposure to a
viremic partner that is associated with these responses.
Receptive sexual exposure drives the T cell immune
response
The type of exposure was further analyzed in the VP group by
assessing the average number of unprotected receptive (Figure 3A)
versus insertive (Figure 3B) anal intercourse episodes. All the
individuals in this study engaged in both activities. Significant
correlations were only seen between the IFN-c responses and the
number of receptive exposures. Again, responses against HIV-1
Protease, RT, Integrase, and Nef derived peptides correlated with
the immune response. Gag followed the trend but did not reach
significance, while CEF responses showed no correlation. There
were no significant correlations between the average number of
insertive exposures and IFN-c responses towards HIV-1 Protease,
RT, Integrase and Nef. As expected, data from the NVP group did
not show a correlation between the IFN-c responses and the
direction of exposure (data not shown).
Table 1. Clinical parameters of each study group.
Viremic Partner Non-Viremic Partner P-value
(Mean6SEM) (Mean6SEM) (two-tailed)
Number (n = ) 20 29 n/a
Participant’s age (years) 42.2061.76 41.7661.75 0.86
Infection duration (days) 39346535.40 40266449.10 0.90
CD4 Count 503.1660.95 559.2656.45 0.51
Time on treatment (days) 21116375.10 25946373.20 0.38
Relationship Length (years) 4.0561.13 3.2260.90 0.56
doi:10.1371/journal.ppat.1000185.t001
Author Summary
Serosorting, the practice of seeking to engage in
unprotected sexual activities only with partners who are
of the same HIV-1 status, is a growing trend. Unprotected
sexual intercourse between two HIV-1 infected individuals
can lead to consequences such as HIV-1 super-infection.
However, continued exposure to HIV-1 may also have an
important influence on the immune response. Here, we
explored this influence in a cohort of HIV-1 infected
individuals who were in long-term partnerships with other
HIV-1 infected individuals. We found that individuals, who
regularly engaged in unprotected receptive sexual inter-
course with an HIV-1 infected viremic partner, displayed
higher T cell responses to HIV proteins compared to those
who were not regularly exposed to a viremic partner. None
of the individuals within this study showed evidence of
systemic super-infection. Exposure had limited impact on
general activation or poly-functionality. These results are
clearly of importance for HIV-1 infected individuals who
chose to engage in unprotected sexual activity with other
HIV-1 infected individuals. These data also reveal a more
general mechanism that occurs in infectious diseases:
immune responses to chronic viruses are influenced not
only by the virus within the host, but also by exposure to
the virus from without.
Immunization Induced by Continued Exposure to HIV-1
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Table 2. Sexual exposure and direction of exposure to a partner between the two groups.
Viremic Partner Group Non-Viremic Partner Group P-value
(Mean6SEM) (Mean6SEM) (two-tailed)
Exposure Score 0.0760.02 0.1160.02 0.23
Receptive Average 8.1562.07 12.4762.84 0.27
Insertive Average 7.0561.80 12.7162.82 0.13
Exposure Outside of Partnership 4.6662.154 8.4264.38 0.48
doi:10.1371/journal.ppat.1000185.t002
Figure 1. Responses to HIV-1 peptides and the CEF pool. A) Percentage of individuals making responses from either group: solid bars indicate
the viremic partner group and open bars represent the non-viremic partner group. There was a significant difference in the number of individuals
responding to Protease and Integrase peptide pools (p = 0.04 and p= 0.002 respectively), as determined by Fishers exact test. No difference was seen
for any other stimuli. B) Magnitude of IFN-c T cell responses to the HIV-1 or CEF peptide pools, and the total cumulative anti-HIV-1 response.
Responses from individuals within the viremic partner group (closed symbols) and individuals within the non-viremic partner group (open symbols)
showed significant differences for Protease, RT, Integrase and the total cumulative anti-HIV-1 response, *p,0.001 and **p = 0.0274 respectively. The
median of each group is plotted as a horizontal line.
doi:10.1371/journal.ppat.1000185.g001
Immunization Induced by Continued Exposure to HIV-1
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Both CD4+ and CD8+ T cells made HIV-1 specific IFN-c
Responses
To determine which T cell subset was responsible for the IFN-c
response detected in the ELISpot assay, individuals from the viremic
partner group (n=7) were screened by flow cytometry. Individuals
were tested using the same 15mer peptide pools used in the ELISpot
assay. Both CD4+ and CD8+ T cell subsets produced IFN-c in
response to all the HIV-1 peptide pools (Figure 4). However, no
significant difference between the two subsets was seen, although
there was a trend towards the CD8+ T cell subset.
Exposure had no effect on poly-functionality or the level
of total activation
In recent studies poly-functional T cells have been associated
with slower disease progression [12]. PBMC from 8 individuals
from the viremic partner group and 10 from the individuals from
the non-viremic partner group were stimulated with 15mer
peptide pools covering HIV-1 Gag and RT. CD4+ and CD8+ T
cell expression of IFN-c and IL-2 were measured by multi-
parametric flow cytometry (Figure 5). No significant difference in
the level of poly-functionality was seen between the two groups,
although there was a trend for greater responses in the viremic
partner group. IL-2 expression by CD8+ T cells was significantly
higher (p = 0.0059) in the viremic partner group compared to the
non-viremic partner group. In the positive control, SEB
stimulation, revealed poly-functional T cells (data not shown).
The total level of T cell activation was measured by CD38 and
HLA-DR expression. No significant difference was seen in the level
of expression of the activation marker CD38 on either CD4+ or
CD8+ T cells (Figure 6 A and B). However, there was a significantly
higher level of CD38+ and HLA-DR+ double positive CD8+ T cells
in the viremic partner group (p=0.0312), although this was not
reflected in the CD4+ T cell subset (p= 0.5148) (Figure 6 C and D).
Decreased exposure is mirrored by decreased T cell
responses
Seven individuals from the viremic partner group had PBMC
samples available from a one year follow up time point. All the
individuals continued to suppress their viral load below the level of
detection (,50 copies/ml) and their CD4+ T cell count remained
constant (Table 3). The exposure scores generated from the second
time point showed little change in exposure levels in the majority
of individuals (Figure 7A). However, two individuals from the
viremic partner group had partners who started anti-retroviral
therapy and were suppressing their viral loads at the second time
point, one year after the first (Figure 7A filled squares). Both
Figure 2. Correlations of exposure to a partner’s HIV-1 and T cell IFN-c response. IFN-c T cell responses from the viremic partner (VP)
group (A), or non-viremic partner (NVP) group (B), were plotted against the corresponding exposure scores against the peptide pools derived from
CEF, or HIV-1 proteins Gag, Protease, RT, Integrase, and Nef. The cumulative anti-HIV-1 T cell IFN-c response was also plotted. Significant correlations
(denoted by *) were determined by two-tailed nonparametric spearmans correlation, spearman r (r), and linear regression analysis was plotted as a
straight line.
doi:10.1371/journal.ppat.1000185.g002
Immunization Induced by Continued Exposure to HIV-1
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individuals also showed a drop in exposure, which was mirrored
by a drop in the response to RT, although responses to Gag did
not change (Figure 7B and C). A third individual whose exposure
score dropped dramatically at the second time point also showed a
drop in their RT response (Figure 7D). One individual had a
modest increased the level of exposure to their partner compared
to the pervious time point. However, no responses to either Gag or
RT were detectable at either time point (Figure 7E).
No other clinical parameter influenced the T cell response
T cell responses can be influenced by a number of other factors
in addition to direct viral antigen stimulation. In order to account
for this, we analysed the responses measured in the VP group
against a number of clinical parameters (Table 4). Only significant
correlations could be found for the length of time the individuals
were on therapy and responses to Protease and RT. However, this
association was confounded by exposure. In a least squares linear
regression model where time on treatment and exposure effects
was independently controlled, time on treatment provided no
additional explanatory power. In fact, the effect of treatment on
both RT and Protease T cell responses completely washed out
(r = 0.014, p = 0.94; and r = 0.14, p= 0.51 respectively), while the
effect of exposure remained high and significant in the model
overall (r2 = 0.56, p= 0.001; r2 = 0.551, p= 0.001 respectively).
Figure 3. Direction of exposure and T cell IFN-c response correlations. IFN-c T cell responses from the viremic partner (VP) group were
plotted against the corresponding average number of unprotected receptive (A) or insertive (B) anal exposures to a partner’s HIV-1. Significant
correlations (denoted by *) were determined by two-tailed nonparametric spearmans correlation, spearman r (r), and linear regression analysis was
plotted as straight lines.
doi:10.1371/journal.ppat.1000185.g003
Immunization Induced by Continued Exposure to HIV-1
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We found no correlation between any of the other parameters and
the magnitude of the T cell IFN-c responses.
HIV-1 Super-infection?
The most likely mechanism, by which these responses are
maintained or boosted in the individuals with viremic partners, is
through the infection of host cells. Thus, potentially these
individuals could be super-infected with their partner’s HIV-1.
To address this concern we used phylogenetical analysis to assess
all the patients within this study at both Gag (data not shown) and
Pol (Figure 8). Population analysis of the individual’s cellular DNA
and partner’s plasma RNA revealed no evidence of systemic super-
infection in any of the individuals studied within either group.
Discussion
The consequence of continued exposure to HIV-1 in individuals
already infected, to our knowledge has never been reported. This
is becoming increasingly relevant with the advent of a growing
trend for serosorting, the practice of seeking to only engage in
unprotected sexual activities with partners who are of the same
HIV-1 status [1,2]. The study set out to measure the impact of
continued exposure to HIV-1 on anti-HIV-1 T cell responses in
individuals already infected.
Here, we have shown that HIV-1+ individuals who are
regularly exposed to an HIV-1+ viremic long-term partner display
greater HIV-1-specific CD4+ and CD8+ T cells responses, than
infected subjects with aviremic partners. Furthermore, in these
individuals the magnitude of the T cell IFN-c response towards
Pol and Nef significantly correlated with the level of exposure.
Longitudinally, RT responses mirrored the level of exposures.
These observations are further strengthened by the fact that
only the number of receptive events correlated with the T cell
IFN-c responses and not the number of insertive events. This is
consistent with the observation that receptive intercourse repre-
sents a greater risk of acquiring HIV infection compared to
insertive intercourse [13].
It is interesting to note that responses were predominantly directed
towards HIV-1 Pol proteins rather than to HIV-1 Gag proteins. This
is in agreement with Karlsson et al, who showed responses switch
from predominantly Gag to Pol in individuals on antiretroviral
therapy [14]. Moreover, it was the RT responses that mirrored
decreases in exposure longitudinally, suggesting that RT-specific
responses are more susceptible to antigen levels compared to Gag.
The responses observed reflect the engagement of host T cells
with cells infected by exogenous HIV-1. These responses could be
driven by three possible sources of viral antigen: via antigen
presented on partner-derived cells within the seminal fluids, super-
infection of host cells, or virion derived proteins.
The presentation of viral antigens on a partner’s HLA can occur
on partner-derived cells or cell-free HLA molecules within the
seminal fluids [15,16]. However, this is unlikely to be the sole
mechanism for stimulating the host immune response, as this could
only occur through HLA alleles that are shared by both partners.
A more likely explanation involves the infection of host cells with a
partner’s virus.
Viral suppression within the peripheral blood by HAART has
been shown not to be mirrored within the gut mucosal layer,
where limited viral replication has been measured [17,18].
Therefore, it is possible that the alleviation of drug pressure
within the mucosal layer could allow a limited super-infection.
Phylogenetic analysis of all the patients within this study revealed
no evidence of systemic super-infection. However, this does not
exclude limited or localized super-infections within the gut.
Free virus within the semen could provide enough antigenic
stimuli to act as a ‘‘natural’’ immunogen. Proteins present in the
viral particle have been shown in vitro to be sufficient to induce
both cytotoxicity and IFN-c secretion by CD8+ T cells, prior to
Figure 4. IFN-c responses are derived from both CD4+ and CD8+ T cells. CD4+ (open boxes) and CD8+ (shaded boxes) T cell IFN-c responses
towards HIV-1 derived peptide pools Gag, Protease, RT, Integrase and Nef, plus the cumulative anti-HIV-1 response and a SEB positive control. No
significant difference was observed between the two T cell subsets (n = 5).
doi:10.1371/journal.ppat.1000185.g004
Immunization Induced by Continued Exposure to HIV-1
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viral replication within an infected CD4+ T cells [19,20]. This
suggests that a response could be stimulated in vivo in the absence
of viral integration.
The ability of HIV-1 to induce an immune response, but remain
undetectable at the peripheral level, has been shown in exposed
uninfected individuals [21,22,23]. In particular this has been
shown in health care workers who only received very limited HIV-
1 exposure [24]. Furthermore, it is well established that discordant
partners and sex workers, regularly exposed to HIV-1, can
generate an anti-HIV-1 T cell response while remaining
uninfected. However, it is noteworthy that this apparent
protection can be lost after just temporarily ceasing exposure
[25,26,27]. This suggests that HIV-1 can act as a potent
immunogen, capable of generating immune responses either in
the absence of infection or at levels below the current level of
detection. Indeed, the site of inoculation appears to play a role too.
A low dose of X4 SHIVSF33A induces potent cellular immunity via
the vaginal route of inoculation [28]. Furthermore, HIV-1
chronically infected individuals have been shown to exhibit robust
multifunctional CD8+ T cell responses within the rectal tissue
[29,30]. Macaques initially infected with live attenuated SIV, show
protection against subsequent intrarectal challenge with a more
virulent strain [31,32,33,34]. This protection from super-infection
was thought to involve local CD8+ T cell immunity. However, in
Figure 5. Exposure did not increase poly-functionality. The ability of CD8+ (A) and CD4+ (B) T cells to express IFN-c and IL-2 was assessed in
both the VP group (shaded boxes, n = 5) and NVP group (open boxes, n = 8). Poly-functionality was determined by the expression of both cytokines.
Only the percentage of IL-2 expressing CD8+ T cells was significantly higher in the VP group (p = 0.0059), denoted by *.
doi:10.1371/journal.ppat.1000185.g005
Immunization Induced by Continued Exposure to HIV-1
PLoS Pathogens | www.plospathogens.org 7 October 2008 | Volume 4 | Issue 10 | e1000185
Figure 6. Total T cell activation was not influenced by exposure. The expression level of activation markers CD38 and HLA-DR were
compared between VP group (squares, n = 6) and NVP group (circles, n = 10). The expression of CD38 on total CD4+ (A) and total CD8+ (B) T cells
showed no significant difference. No significant difference was seen in CD4+ T cell co-expression of CD38 and HLA-DR (C). However, CD8+ T cells from
the VP group co-expressed significantly higher of CD38 and HLA-DR compared to the NVP group (denoted by *) (D).
doi:10.1371/journal.ppat.1000185.g006
Table 3. Clinical data of 8 individuals from VPG at time point 0 and 1 year later at time point 1.
Individual Time point 0 Time point 1
Weighted
Exposure Score
CD4
Count
Viral
Load
Receiving
therapy
Weighted
Exposure Score
CD4
Count Viral Load
Receiving
therapy
1* 0.3100 636 ,50 Yes 0.1469 637 ,50 Yes
2 0.0900 654 ,50 Yes 0.0112 462 ,50 Yes
3 0.0700 598 ,50 Yes 0.0246 575 ,50 Yes
4 0.1000 452 ,50 Yes 0.0747 432 ,50 Yes
5 0.0800 294 ,50 Yes 0.0080 434 ,50 Yes
6* 0.0700 543 ,50 Yes 0.0000 532 ,50 Yes
7 0.0600 650 ,50 Yes 0.0492 675 ,50 Yes
8 0.0400 260 ,50 Yes 0.1403 532 ,50 Yes
*indicates that the individuals partner started to receive anti-retroviral therapy after time point 0, and had a viral load below 50 copies per ml.
doi:10.1371/journal.ppat.1000185.t003
Immunization Induced by Continued Exposure to HIV-1
PLoS Pathogens | www.plospathogens.org 8 October 2008 | Volume 4 | Issue 10 | e1000185
this study only limited differences between the level of poly-
functionality and total activation were observed between the VP
and NVP groups. This suggests that although exposure to
exogenous HIV-1 can maintain responses, it cannot alter the
functionality of the T cells, although further studies are needed.
The ability of exogenous HIV-1 to shape an immune response
has important implications for HIV-1 infected individuals who
choose to engage in unprotected sex with other HIV-1 infected
individuals. The goal of therapeutic immunization strategies in
HIV-1 infected people is to maintain strong anti-HIV-1 immune
responses in individuals on HAART (reviewed in [35,36]). Here,
we have observed a ‘‘natural immunization’’ with live infectious
virus delivered to the rectal mucosa. While the maintenance of an
anti-HIV-1 response may be considered a positive outcome,
individuals engaging in unprotected sexual intercourse with other
HIV-1 infected individuals could be at risk of super-infection,
Figure 7. RT responses follow changes in exposure longitudinally. Exposure scores generated from questionnaires at the first time (time
point 0) and 1 year later (time point 1) were compared for 7 individuals from the viremic partner group (A). Two individual’s partners started anti-
retroviral therapy between the time points and their viral loads were below the level of detection at the second time point (filled squares). ELISpot
technology was employed to measure IFN-c responses. Two individuals with aviremic partners at the second time point also showed a decrease in
exposure to their partner (B and C), which was reflected in their anti-HIV-1 RT response. This was also seen in a third individual whose exposure
dropped dramatically at the second time point (D). One individual showed an increase in their level of exposure, however, there was no responses
was above background (,50 SFU) (E).
doi:10.1371/journal.ppat.1000185.g007
Immunization Induced by Continued Exposure to HIV-1
PLoS Pathogens | www.plospathogens.org 9 October 2008 | Volume 4 | Issue 10 | e1000185
which would be particularly detrimental if the super-infecting virus
carried drug resistant mutations. Furthermore, these maintained
responses remained limited in functionality, suggesting the
‘‘quality’’ of the responses was not improved.
Although none of the study participants showed evidence for
super-infection at the systemic level (in which a new virus
overgrows the resident strain), we cannot rule out potential
compartmentalized super-infections within the rectal tissues, or
super-infections that were cleared locally. Moreover, all of the
study individuals were on successful HAART (VL,50 copies/ml),
which could also limit infection with exogenous HIV-1.
We propose that HIV-1 exposure can lead to infection in
susceptible individuals, but also act as a potent ‘‘natural’’
immunogen in individuals already infected. The mechanism/s
behind the immunogenicity of exposure to a partner’s HIV-1
remains unclear. However, we speculate that the maintenance of
the anti-HIV-1-specific T cell response most likely reflects limited
super-infection within the rectal tissues. However, catching a
partner’s HIV-1 in the act of super-infecting an exposed partner’s
tissues will be a technically challenging task.
This data also reveals a more general mechanism that occurs in
infectious diseases; immune responses to chronic virus infections in
a host are influenced not only by the chronic virus within the host,
but also by exposure to exogenous virus from without.
Materials and Methods
Study design
We selected 49 individuals from the San Francisco Positive
Partners prospective couples cohort study based on specific
criteria: they had been on highly active antiretroviral therapy
(HAART) for over 3 months and had viral loads under the limit of
quantification on a sensitive assay (,50 copies/ml), they had a co-
enrolled partner who was also HIV-1 positive and who was either
viremic (the lowest viral load was .8000 copies/ml) or had a viral
load ,50 copies/ml. All subjects were men who have sex with
men (MSM).
From these study subjects two groups were created based on the
partner’s viral load. The first group comprised of individuals with
viremic partners, viremic partner (VP) group, and the second
included subjects with virologically suppressed partners (,50
copies/ml), non-viremic partner (NVP) group. The two groups did
not differ in terms of age, CD4 count, time on therapy, length of
time infected, or time with partner (Table 1).
Assessment of Exposure
Sexual exposure data were derived from self-administered
questionnaires completed by both partners independently regard-
ing sexual practices during the past three months. The
instrumentation was based upon one of the few questionnaires
ever developed to measure sexual behavior that has been
extensively validated [37,38]. It was adapted to the study of
HIV-positive seroconcordant partnerships and extensively piloted
and revised prior to the enrollment of the couples in this sub study.
An exposure score was calculated from the number of times the
subject reported they had had unprotected receptive anal
intercourse with their partner, and the number of times their
partner reported they had unprotected insertive anal intercourse
with the subject. This gave an average receptive exposure score,
which was multiplied by the associated risk of infection per
Table 4. The influence of clinical parameters on T cell responses.
Viremic Partner Group CEF Gag Protease RT Integrase Nef Total
Age
Spearman r 20.1570 0.2030 0.1160 0.2200 0.1410 0.0825 0.1740
P value (two-tailed) 0.5336 0.3910 0.6272 0.3650 0.5762 0.7295 0.4633
Significance ns ns Ns ns ns ns ns
Time on Therapy
Spearman r 20.1020 0.3340 0.4850 0.4190 0.2350 0.3230 0.3550
P value (two-tailed) 0.6867 0.1506 0.0303 0.0738 0.3489 0.1642 0.1247
Significance ns ns { { ns ns ns
CD4 Count
Spearman r 20.1520 20.0497 0.3740 0.2900 0.1600 0.2950 0.2930
P value (two-tailed) 0.5479 0.8352 0.1045 0.2276 0.5256 0.2070 0.2096
Significance ns ns Ns ns ns ns ns
Partners Viral Load
Spearman r 0.2320 20.2470 20.1870 20.0377 20.0816 20.0015 20.0241
P value (two-tailed) 0.3538 0.2938 0.4292 0.8781 0.7475 0.9950 0.9198
Significance ns ns Ns ns ns ns ns
Infection duration
Spearman r 20.1210 0.1650 0.2130 0.2610 0.1750 0.1200 0.1650
P value (two-tailed) 0.6332 0.4872 0.3675 0.2811 0.4884 0.6155 0.4858
Significance ns ns Ns ns ns ns ns
*indicates significant correlations.
{denotes significant correlations that did not hold when tested by least squares linear regression.
ns = no significant correlation could be found.
doi:10.1371/journal.ppat.1000185.t004
Immunization Induced by Continued Exposure to HIV-1
PLoS Pathogens | www.plospathogens.org 10 October 2008 | Volume 4 | Issue 10 | e1000185
receptive exposure for HIV-1 negative individuals through this
type of exposure [13]. The insertive exposure score was calculated
in a similar manner and multiplied by the associated risk of
infection per exposure for unprotected insertive anal intercourse
[13]. The sum of these averages gave a final exposure score. All
immunological studies were performed blinded to the exposure
data.
In addition to sexual exposure to an enrolled partner the same
sexual exposure measures were asked of all other sexual partners in
the past three months. There was no significant difference in
exposure with non-enrolled partners between the VP and NVP
groups (Table 2). Although the HIV-status of most non-enrolled
partners was known, knowledge of treatment status was irregular,
and neither self-reports nor laboratory values of viral load were
available for these partners. Therefore, outside partnerships
provided no additional data useful in this analysis.
Study subjects
The study included 49 study subjects from the San Francisco
Positive Partners prospective couples study. HIV-1-positive
seroconcordant sexual partnerships were enrolled in this study if
they reported unprotected intercourse. All subjects, in this sub-
sample were MSM, who had been HIV-1 positive for over 2 years
and were currently suppressing their virus, below 50 copies/ml,
while on HAART.
ELISPOT Analysis of T-cell responses
T cell responses were determined by IFN-c ELIspot assay as
previously described [39]. Overlapping peptides of 15–18 amino
acids in length were employed, which encompassed HIV-1
consensus B (NIH) Gag, Protease, Reverse Transcription (RT),
Integrase, and Nef. In addition, a non-HIV-1 viral peptide pool
comprising of peptides from Cytomegalovirus, Epstein-Barr virus,
and Influenza (CEF) was used as an additional control. Cryopre-
served PBMCs were thawed and plated at 105 cells were well, with a
final peptide concentration of 1 mg/ml. All spot numbers were
normalized to numbers of IFN-c spot-forming units (SFU) per 106
PBMCs. Spot values from medium control wells were subtracted to
determine responses to each peptide. Responses were determined as
either greater than two times background, or greater than 50 SFU/
106 PBMCs, which ever was the higher. All experiments were
conducted blinded to the individuals exposure score.
Cell staining and flow cytometric analysis
Cryopreserved PBMCs were thawed and washed with complete
media. For functional assays PBMCs were incubated with 2 mg/ml
peptide pools plus anti-CD28 and anti-CD49d (BD Biosciences,
San Diego) at 1 mg/ml, as describe above and after 30 min
Brefeldin A was added to the cultures. Cultures were left for a
further 7 hours and 30 minutes at 37uC, washed and stained.
Flourochrome conjugated antibodies directed against cellular
Figure 8. Phylogenetic analysis showed no evidence for systemic super-infection. No individuals studied in either the viremic partner
group (A), or the non-viremic partner group (B) showed evidence of systemic super-infection by phylogenetic analysis. A unique partnership number
indicates each partnership. No bootstrap values above 70% (indicated at each branch point) were generated between partner’s viral sequences taken
from the same time point, indicating their viruses were significantly divergent and no super-infection had occurred. * Known infecting partners.
doi:10.1371/journal.ppat.1000185.g008
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molecules: CD3 (Beckman coulter), CD4, CD8, IFN-c, and IL-2
(all BD Biosciences), were used to stain cells. In addition the
activation markers CD38 and HLA-DR (both BD Biosciences),
were also stained for ex vivo in conjunction with CD3 (Beckman
coulter), CD4 and CD8 (both BD Biosciences). Positive controls
were Staphylococcal enterotoxin B (SEB) (Sigma). Data was
acquired with a LSRII (BD Biosciences), and analyzed using
FlowJo software (TreeStar).
Statistical analysis
Statistical significance and graphical presentations were com-
pleted using GraphPad Prism version 4.00 for Windows,
GraphPad Software, San Diego California USA, www.graphpad.
com, or Microsoft Excel version 2003, Microsoft Corporation.
Differences in the proportion of individuals responding to the
various antigens were analyzed by Fishers Exact test (two-tailed).
Statistical analysis of the response magnitudes was completed
using a Mann-Whitey test. Correlations were determined by two-
tailed nonparametric Spearman correlation, Spearman r-values
are also given. Linear regression analysis was plotted on each
correlation as a straight line. Least squares linear regression
models were executed using SPSS statistical package version 11.5.
HIV-1 Sequencing
The sequence of HIV-1 reverse transcriptase and protease was
performed using the TRUGENE HIV-1 RNA genotyping kit and
OpenGene system software for sequence analysis (Siemens
Medical Solutions Diagnostics) [40,41]. Mixtures are designated
with standard ambiguity codes when representing 30% or greater
minor variant at any particular base. Viral RNA from blood
plasma was extracted using the Qia-Amp viral RNA kit (Qiagen),
reverse transcribed, amplified and sequenced in subjects with
sufficient viremia (.100 copies/mL). Proviral DNA from PBMC
was amplified after extraction using the DNeasy tissue kit (Qiagen)
and sequenced in samples from subjects with low (,100 copies/
mL) or undetectable (,50 copies/mL) plasma viremia. Codons 1–
99 of protease and 40 through 247 of reverse transcriptase were
sequenced and analyzed in all samples.
Phylogenetic Analysis
HIV-1 sequences were obtained from the HIV-1 Pol region and
sequenced. All sequences were assembled using BioEdit v.7.0.4.1
and aligned with the Clustal X v1.83 sequence alignment tool.
Phylogenetic analysis was done using neighbor-joining trees with
bootstraps generated using Clustal X. We used 1000 random
samples of sites from the alignment, drawing 1000 trees (1 from
each sample) and counted how many times each grouping from
the original tree occurs in the sample trees.
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